Intravenous (IV) access devices are utilized by physicians to deliver medication to the patients’ bloodstream through the intravenous route and also to withdraw blood for testing purpose. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate. Intravenous therapy may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement to correct, for example, dehydration. Intravenous therapy could also be used for chemotherapy. The rising global incidence rates of chronic diseases such as cancer, diabetes, and cardiovascular disorders, along with acute infectious diseases, has tremendously increased the demand for IV access devices used to administer drugs to patients.
The global intravenous access devices market segmentation is based on product types (intravenous needles, intravenous catheters, midline peripheral catheters, central catheters, peripherally inserted central catheters, centrally inserted central catheters, intravenous infusion pumps, insulin infusion pumps, parenteral feeding infusion pumps, patient controlled analgesia infusion pumps, syringe infusion pumps).
The global intravenous access devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global intravenous access devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global intravenous access devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global intravenous access devices market and included in this report are Hospira, Inc., Becton, Dickinson & Company, CareFusion Corporation, Baxter International, Medtronic, Inc. and Covidien Plc.